某院中西医结合疗法对新型冠状病毒肺炎患者的临床疗效评价

Evaluation on Clinical Efficacy of Integrative Chinese and Western Medicine in Patients with COVID-19 in Our Hospital

目的:评价中西医结合疗法对新型冠状病毒肺炎(COVID-19)患者的临床疗效。方法:选取2020年1月26日—2020年2月11日间收治的被确诊为COVID-19患者65例临床资料,按治疗方法的不同将其分为西医治疗组35例(采用西药治疗)和中西医结合治疗组30例(采用中西医结合治疗);比较两组患者不同疗法治疗前后的临床症状改善率和实验室各指标测得值的变化情况。结果:中西医结合治疗组对临床症状和实验室各指标均稍优于西医治疗组,经组间比较其差异有统计学意义(P<0.05)。结论:采用中西医结合疗法有效促进了COVID-19患者临床症状的改善和肺部病灶的吸收,提高了临床疗效。

Objective:To evaluate the clinical efficacy of integrated Traditional Chinese and Western medicine in patients with corona virus disease 2019(COVID-19).Methods:The clinical data of 65 patients with confirmed COVID-19 admitted from January 26,2020 and February 11,2020 were selected.Based on different treatment methods,the patients were divided into the western medicine treatment group(35 patients treated with western medicine)and the integrated Traditional Chinese and Western medicine treatment group(30 patients treated with integrated Traditional Chinese and Western medicine).The clinical symptom improvement rate and the changes in the measured values of laboratory indicators before and after different treatments in the two groups were compared.Results:The clinical symptoms and laboratory indexes of the combined Chinese and Western medicine treatment group were all better than those of the western medicine treatment group.The difference between the two groups was statistically significant(P<0.05).Conclusion:The combination of Traditional Chinese and western medicine had effectively promoted the improvement of clinical symptoms and the absorption of lung lesions in COVID-19 patients,and improved the clinical efficacy.